ENSOCELL LTD
No Analysis Available
Get instant AI-powered insights about this company's financial health, risks, and trends.
Order Analysis - £10- Legal registered address
- Biodata Innovation Centre Wellcome Genome Campus Cambridge England CB10 1DR Copied!
Latest financial results as of 19 August 2025- Cash in bank
- £6.58m
- Current assets
- £8.04m
- Current creditors
- £66.32k
- Shareholders funds
- £13.00m
View full financial accounts- Cash in bank
- £6.58m
- Current assets
- £8.04m
- Current creditors
- £66.32k
- Shareholders funds
- £13.00m
- Company number
- 14714531 Copied!
Accounts
Latest annual accounts were to 30 September 2024
Next annual accounts are due by 31 December 2025
Company financial year end is on 31 March 2026
Confirmation statement
Latest confirmation statement statement dated 7 March 2025
Next statement due by 21 March 2026
Nature of business (SIC)
72110 - Research and experimental development on biotechnology
Previous company names
| Name | Date previous name changed |
|---|---|
| ENSOTX LTD | 6 July 2023 |
Latest company documents
| Date | Description |
|---|---|
| 29/04/2529 April 2025 | Second filing of a statement of capital following an allotment of shares on 2025-02-24 |
| 31/03/2531 March 2025 | Annual accounts for year ending 31 Mar 2025 |
| 14/03/2514 March 2025 | Confirmation statement made on 2025-03-07 with updates |
| 05/03/255 March 2025 | Statement of capital following an allotment of shares on 2025-02-24 |
| 30/12/2430 December 2024 | Resolutions |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company